Preprint Open Access

Influenza and acellular pertussis vaccines not only fail to protect, they increase susceptibility and severity of disease upon infection – benefits are overrated and the risks are being ignored

Arumugham, Vinu

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="" xmlns="" xsi:schemaLocation="">
  <identifier identifierType="DOI">10.5281/zenodo.2532167</identifier>
      <creatorName>Arumugham, Vinu</creatorName>
    <title>Influenza and acellular pertussis vaccines not only fail to protect, they increase susceptibility and severity of disease upon infection – benefits are overrated and the risks are being ignored</title>
    <subject>mucosal immunity</subject>
    <subject>cell mediated immunity</subject>
    <subject>linked epitope suppression</subject>
    <subject>aluminum adjuvant</subject>
    <subject>multiple sclerosis</subject>
    <date dateType="Issued">2019-01-05</date>
  <resourceType resourceTypeGeneral="Text">Preprint</resourceType>
    <alternateIdentifier alternateIdentifierType="url"></alternateIdentifier>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.2532166</relatedIdentifier>
    <rights rightsURI="">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
    <description descriptionType="Abstract">&lt;p&gt;The influenza vaccine fails often. The influenza vaccines cause the development of IgE mediated&lt;br&gt;
allergy to the influenza virus. The reason for failure include antigenic mismatch between vaccine strain&lt;br&gt;
and wild virus, IgE mediated antigen neutralization, etc. Naturally acquired immunity against influenza&lt;br&gt;
lasts for decades. Vaccine based immunity lasts for a few months. Replacing natural immunity with&lt;br&gt;
vaccine-based immunity, progressively increases susceptibility over time. In 2016-18, between 46 and&lt;br&gt;
68% of patients admitted to the ICU for severe influenza were vaccinated with the influenza vaccine, in&lt;br&gt;
California. The influenza vaccine uptake in the general population in California during that same period&lt;br&gt;
was between 40-48%. This adds to evidence that not only does the influenza vaccine fail, it can&lt;br&gt;
contribute to increased disease severity. The increase in disease severity is due to patients suffering an&lt;br&gt;
allergic reaction against the virus, concurrent with the influenza infection.&lt;br&gt;
The acellular pertussis vaccine (APV) fails to protect for more than a year in most patients, fails to&lt;br&gt;
provide mucosal immunity, fails to provide cell mediated immunity and fails to protect against airway&lt;br&gt;
colonization with Bordetella pertussis (BP) bacteria. Therefore the APV causes asymptomatic&lt;br&gt;
spreading of BP. The exact opposite effect of herd immunity - herd spreading. The APV causes IgE&lt;br&gt;
mediated sensitization directed against BP antigens. Therefore once colonized, continuing exposure to&lt;br&gt;
BP antigens results in asthma. Colonization with BP can cause multiple sclerosis. The APV contains&lt;br&gt;
cow&amp;rsquo;s milk proteins used to manufacture the vaccine. The milk proteins include bovine casein, bovine&lt;br&gt;
insulin and bovine folate receptor proteins. The result is the development of milk allergy, type 1&lt;br&gt;
diabetes and autism respectively. Colonization can induce immune tolerance to BP, making an infection&lt;br&gt;
even more dangerous and rendering the patient potentially unprotectable for life with a future pertussis&lt;br&gt;

All versions This version
Views 2,0222,023
Downloads 507507
Data volume 30.1 MB30.1 MB
Unique views 1,8561,857
Unique downloads 453453


Cite as